Identification
Symbol
AMT
ISIN code
NL0000886968
Exchange / Market
Euronext
Trading location
Amsterdam
Products family
Stocks
Market organization
EuronextAmsterdam
ICB
Biotechnology
Activity description

<p>
AMT (Amsterdam Molecular Therapeutics) specializes in the development of gene therapy products intended for treating serious, often rare, diseases with a major medical need. The group&#39;s products are based on introducing genes into target organs and tissues in order to accomplish the long-term expression of the genes and correct the genetic defects causing the disease. AMT has a portfolio of 5 products: 3 in late stage pre-clinical development (for treating Parkinson&#39;s Disease, Duchenne Muscular Dystrophy and Porphyria), 1 in the Phase I/II clinical study (for treating Hemophilia B) and 1 in the marketing phase (Glybera&reg; for treating lipoprotein lipase deficiency).</p>

Website address
Issuer website
www.amtbiopharma.com
Operation
IPO date
IPO price
2.03
IPO type
New Issue Special Session
Catégorie
New Issue Special Session
Operation procedure

<p>
OFFER SHARES</p>